英文名稱 |
中文名稱 |
CAS號 |
操作 |
Cholecalciferol Impurity 2 |
7-脫氫鏈甾醇 |
1715-86-2 |
詳細(xì)
|
Relugolix Impurity 10 |
瑞盧戈利雜質(zhì)82 |
2814571-30-5 |
詳細(xì)
|
Labetalol Impurity 11 |
(S,R)-拉貝洛爾 |
83167-31-1 |
詳細(xì)
|
Labetalol EP Impurity A |
拉貝洛爾雜質(zhì)A |
1391051-99-2 |
詳細(xì)
|
Ketorolac EP Impurity G |
酮咯酸雜質(zhì)G |
1391051-90-3 |
詳細(xì)
|
Hydrocortisone EP Impurity E |
氫化可松EP雜質(zhì)E |
600-99-7 |
詳細(xì)
|
Ketorolac EP Impurity I |
1-脫羧酮咯酸 |
113502-55-9 |
詳細(xì)
|
Oxaliplatin Ep Impurity A |
草酸 |
144-62-7 |
詳細(xì)
|
Labetalol EP Impurity D |
Benzamide, 5-(2-amino-1-hydroxyethyl)-2-hydroxy- |
68807-83-0 |
詳細(xì)
|
Labetalol Impurity 5 |
拉貝洛爾雜質(zhì)10 |
2731858-23-2 |
詳細(xì)
|
Relugolix Impurity 3 |
瑞盧戈利雜質(zhì)16 |
2814571-35-0 |
詳細(xì)
|
Mitoxantrone EP Impurity B |
米托蒽醌雜質(zhì)B |
80189-44-2 |
詳細(xì)
|
Mitoxantrone EP Impurity D |
米托蒽醌雜質(zhì)D |
137132-70-8 |
詳細(xì)
|
Relugolix Impurity 13 |
|
2814572-20-6 |
詳細(xì)
|
Raloxifene EP Impurity C |
雷洛昔芬雜質(zhì)C |
195454-31-0 |
詳細(xì)
|
Raloxifene EP Impurity B |
雷洛昔芬EP雜質(zhì)B |
1391054-73-1 |
詳細(xì)
|
Ketorolac EP Impurity D |
酮咯酸雜質(zhì)D |
1391053-45-4 |
詳細(xì)
|
Verapamil EP Impurity O |
維拉帕米雜質(zhì)O |
959011-16-6 |
詳細(xì)
|
Ketorolac EP Impurity H |
酮咯酸雜質(zhì)H |
80965-09-9 |
詳細(xì)
|
Mitoxantrone EP Impurity C |
米托蒽醌EP雜質(zhì)C |
1796928-50-1 |
詳細(xì)
|
Labetalol EP Impurity D HCl |
Labetalol EP impurity D |
32780-65-7 |
詳細(xì)
|
Sulpiride EP Impurity F |
舒必利氮氧化物 |
2214214-03-4 |
詳細(xì)
|
Verapamil EP Impurity C |
維拉帕米EP雜質(zhì)C |
3490-05-9 |
詳細(xì)
|
Glucosamine EP Impurity B |
果糖嗪 |
13185-73-4 |
詳細(xì)
|
Cholecalciferol Impurity 3 |
膽固醇雜質(zhì)32 |
67085-26-1 |
詳細(xì)
|
Sulpiride EP Impurity G |
O-去甲基舒必利 |
67381-52-6 |
詳細(xì)
|
Verapamil EP Impurity A |
維拉帕米EP雜質(zhì)A |
141991-88-0 |
詳細(xì)
|
Verapamil EP Impurity N |
Verapamil Impurity N |
2086274-75-9 |
詳細(xì)
|
Sulpiride EP Impurity C |
2-甲氧基-5-磺酰胺基苯甲酸乙酯 |
33045-53-3 |
詳細(xì)
|
Verapamil EP Impurity M |
維拉帕米雜質(zhì)M |
141991-89-1 |
詳細(xì)
|
Nafamostat Impurity 13 |
7-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate |
2241024-11-1 |
詳細(xì)
|
Betamethasone Valerate EP Impurity C |
戊酸他米松EP雜質(zhì)C |
33755-46-3 |
詳細(xì)
|
Rasagiline Impurity 17 |
雷沙吉蘭雜質(zhì)14 |
10277-76-6 |
詳細(xì)
|
Hydrocortisone EP Impurity O |
氫化可松EP雜質(zhì)O |
154032-37-8 |
詳細(xì)
|
Silodosin Impurity 1 |
5-(2-氨基丙基)-1-[3-(苯甲酰氧基)丙基]-2,3-二氫-1H-吲哚-7-甲腈 |
1338365-54-0 |
詳細(xì)
|
Bexgliflozin Impurity 2 |
4-溴-1-氯-2-(4-(2-環(huán)丙氧基乙氧基)芐基)苯 |
1118567-45-5 |
詳細(xì)
|
Labetalol Impurity 4 |
5-formyl-2-hydroxybenzamide |
76143-20-9 |
詳細(xì)
|
Cefuroxime axetil dimer |
頭孢呋辛酯二聚體 |
1202925-10-7 |
詳細(xì)
|
Hydrocortisone EP Impurity I |
氫化可的松雜質(zhì)I |
103795-84-2 |
詳細(xì)
|
Labetalol EP Impurity B HCl |
5-[1-羥基-2-[(1-甲基-3-苯基丙基)氨基]乙基]水楊酸甲酯鹽酸鹽 |
33778-93-7 |
詳細(xì)
|
Betamethasone EP Impurity J |
倍他米松雜質(zhì) J |
18383-24-9 |
詳細(xì)
|
Betamethasone EP Impurity F |
倍他米松EP雜質(zhì)F |
330157-04-5 |
詳細(xì)
|
Ketorolac EP Impurity J |
酮咯酸乙酯 |
108061-03-6 |
詳細(xì)
|
Phenytoin Sodium EP Impurity E |
苯妥英雜質(zhì)E |
6802-95-5 |
詳細(xì)
|
Labetalol EP Impurity A HCl |
鹽酸拉貝洛爾EP雜質(zhì)A鹽酸鹽 |
2726492-68-6 |
詳細(xì)
|
Nafamostat Impurity 19 |
萘莫司他雜質(zhì)11 |
2491698-53-2 |
詳細(xì)
|
Guaifenesin EP Impurity B |
愈創(chuàng)木酚甘油醚雜質(zhì)B |
14007-09-1 |
詳細(xì)
|
Ketorolac EP Impurity E |
酮咯酸雜質(zhì)E |
167105-80-8 |
詳細(xì)
|
Iomeprol Impurity 1 |
碘佛醇水解物 |
77868-40-7 |
詳細(xì)
|
Nafamostat Impurity 1 |
萘莫司他雜質(zhì)10 |
62529-01-5 |
詳細(xì)
|
Betamethasone EP Impurity I |
倍他米松EP雜質(zhì)I |
185613-69-8 |
詳細(xì)
|
Netarsudil Impurity 3 |
(R)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate |
1253955-20-2 |
詳細(xì)
|
Nicotinamide Impurity 1 |
煙酰胺雜質(zhì)10 |
7298-94-4 |
詳細(xì)
|
Netarsudil Impurity 5 |
Benzeneacetic acid, 4-[[(2,4-dimethylbenzoyl)oxy]methyl]-α-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-, (αR)- |
2098444-97-2 |
詳細(xì)
|
Cholecalciferol Impurity 4 |
|
63819-59-0 |
詳細(xì)
|
Labetalol Impurity 7 |
拉貝洛爾雜質(zhì)8 |
2924103-17-1 |
詳細(xì)
|
Mitoxantrone EP Impurity A |
米托蒽醌雜質(zhì)A |
89991-52-6 |
詳細(xì)
|
Guaifenesin EP Impurity C |
愈創(chuàng)甘油醚EP雜質(zhì)C |
1797132-23-0 |
詳細(xì)
|
Nafamostat Impurity 20 |
6-氰基-2-萘酚 |
52927-22-7 |
詳細(xì)
|
Iomeprol Impurity 5 |
碘美普爾雜質(zhì)1 |
196309-10-1 |
詳細(xì)
|
Labetalol EP Impurity F HCl |
鹽酸拉貝洛爾酮 |
96441-14-4 |
詳細(xì)
|
Upadacitinib Impurity 22 |
[2-[(3R,4S)-4-乙基-1-[(苯基甲氧基)羰基]-3-吡咯烷基]-2-氧代乙基]二甲基-亞砜內(nèi)鹽 |
2050038-78-1 |
詳細(xì)
|
Brimonidine Impurity 2 |
溴莫尼定雜質(zhì)5 |
934548-66-0 |
詳細(xì)
|
Cefcapene Pivoxil Impurity 1 |
頭孢卡品酯 |
135889-00-8 |
詳細(xì)
|
Netarsudil Impurity 4 |
Benzoic acid, 2,4-dimethyl-, [4-[(1R)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester |
1254032-67-1 |
詳細(xì)
|
Guaifenesin Metabolite |
2-羥基-3-(2-甲氧基苯氧基)丙酸 |
13057-65-3 |
詳細(xì)
|
Nafamostat Impurity 3 |
4-UREIDO-BENZOIC ACID |
6306-25-8 |
詳細(xì)
|
Oxaliplatin Ep Impurity D |
奧沙利鉑有關(guān)物質(zhì)D |
61758-77-8 |
詳細(xì)
|
Raloxifene EP Impurity A |
雷洛昔芬雜質(zhì)I |
1159977-58-8 |
詳細(xì)
|
Oxaliplatin Ep Impurity C |
二羥基奧沙利鉑-PT(IV) |
111321-67-6 |
詳細(xì)
|
Labetalol EP Impurity B |
拉貝洛爾雜質(zhì)B |
802620-01-5 |
詳細(xì)
|
Ketorolac EP Impurity F |
酮咯酸雜質(zhì)F |
1391052-68-8 |
詳細(xì)
|
Betamethasone EP Impurity H |
倍他米松EP雜質(zhì)H |
185613-71-2 |
詳細(xì)
|
Labetalol Impurity 3 |
拉貝洛爾雜質(zhì)2 |
1243453-81-7 |
詳細(xì)
|
Diosmin Impurity 1 |
Diosmin Impurity 19 |
67549-69-3 |
詳細(xì)
|
Rasagiline Impurity 15 |
雷沙吉蘭雜質(zhì)25 |
1429316-88-0 |
詳細(xì)
|
Hydrocortisone EP Impurity J |
氫化可松EP雜質(zhì)J |
16463-74-4 |
詳細(xì)
|
Betamethasone EP Impurity G |
倍他米松EP雜質(zhì)G |
85700-75-0 |
詳細(xì)
|
Rasagiline Impurity 14 |
雷沙吉蘭雜質(zhì)13 |
1042563-60-9 |
詳細(xì)
|
Glucosamine EP Impurity C |
2,5-脫氧果糖嗪 |
17460-13-8 |
詳細(xì)
|
Sulpiride EP Impurity E |
舒必利雜質(zhì)E |
52395-25-2 |
詳細(xì)
|
Verapamil EP Impurity D |
N-甲基l-N-(3-氯丙基)-3,4-二甲氧基苯乙胺 |
36770-74-8 |
詳細(xì)
|
Labetalol Impurity 8 |
5-溴乙酰水楊酰胺 |
73866-23-6 |
詳細(xì)
|
Zolpidem Tartrate Impurity 1 |
4-甲基-N-(5-甲基-2-吡啶基)苯甲酰胺 |
349122-64-1 |
詳細(xì)
|
Ketorolac EP Impurity C |
酮咯酸雜質(zhì)C |
1026936-07-1 |
詳細(xì)
|
Verapamil EP Impurity H |
維拉帕米EP雜質(zhì)H HCL |
67018-83-1 |
詳細(xì)
|
Nafamostat Impurity 5 |
二甲雙胍雜質(zhì)19 |
24503-25-1 |
詳細(xì)
|
Labetalol EP Impurity C |
Labetalol EP impurity C |
2386661-13-6 |
詳細(xì)
|
Oxaliplatin Ep Impurity B |
奧沙利鉑EP雜質(zhì)B |
89955-85-1 |
詳細(xì)
|
Verapamil EP Impurity F |
N -甲基- 4 -(3,4 -二甲氧基苯基)- 4 -氰基- 5 - 己基甲胺 |
34245-14-2 |
詳細(xì)
|
Rasagiline Impurity 13 |
雷沙吉蘭雜質(zhì)12 |
92249-77-9 |
詳細(xì)
|
Verapamil EP Impurity P |
維拉帕米EP雜質(zhì)P |
2086275-13-8 |
詳細(xì)
|
Nafamostat Impurity 12 |
Benzoic acid, 3-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester |
82956-09-0 |
詳細(xì)
|
Cholecalciferol Impurity 1 |
|
82395-72-0 |
詳細(xì)
|
Labetalol EP Impurity F |
2-hydroxy-5-[[(1-methyl-3-phenylpropyl)amino]acetyl]benzamide |
85665-85-6 |
詳細(xì)
|
Hydrocortisone EP Impurity D |
6Β-羥基可的松 |
53-35-0 |
詳細(xì)
|
Bexgliflozin Impurity 1 |
貝沙格列凈 |
1118567-05-7 |
詳細(xì)
|
Nafamostat Impurity 2 |
4-(3-氨基甲酰氨基胍基)苯甲酸鹽酸鹽 |
63101-32-6 |
詳細(xì)
|
Verapamil EP Impurity I |
維拉帕米EP雜質(zhì)I |
2893-91-6 |
詳細(xì)
|
Labetalol Impurity 10 |
地瓦洛爾 |
75659-07-3 |
詳細(xì)
|